![]() |
Volumn 23, Issue 4, 2012, Pages 1081-1082
|
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINDAMYCIN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
MINOCYCLINE;
MITOGEN ACTIVATED PROTEIN KINASE;
NICOTINAMIDE;
POLYPHENOL DERIVATIVE;
BACTERIAL INFECTION;
CELL DIFFERENTIATION;
CELL MIGRATION;
CELL PROLIFERATION;
CELL SURVIVAL;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
EVIDENCE BASED MEDICINE;
HUMAN;
KERATINOCYTE;
LETTER;
MOLECULAR DYNAMICS;
MOLECULAR INTERACTION;
MOLECULARLY TARGETED THERAPY;
NONHUMAN;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROTEIN DETERMINATION;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
PROTEIN PHOSPHORYLATION;
QUALITY OF LIFE;
SKIN TOXICITY;
TEA;
|
EID: 84859507031
PISSN: 09237534
EISSN: 15698041
Source Type: Journal
DOI: 10.1093/annonc/mds026 Document Type: Letter |
Times cited : (4)
|
References (5)
|